Pharmacokinetic (PK) and Safety Study of Plasma-derived Human Butyrylcholinesterase Administered Intravenously

Clinical trial NCT00333515 · COMPLETED

Trial details

NCT number: NCT00333515
Sponsor: Baxalta now part of Shire
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Chemical Terrorism Chemical Warfare

Start date: 2007-01-01
Primary completion: 2008-04-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.